Medical company CAN Community Health announced on Friday the appointment of Marlon Pittman as the new director of its Partnership Development.
In the senior position, Pittman will help establish partnerships in areas where HIV prevalence is high. Through the partnerships, the company brings in medical and dental services, counselling and therapy, case management, pharmacy services, additional services, providing a patient with services in one location.
At the start of his career, Pittman has completed an executive leadership programme at the Wharton School of Business in Pennsylvania.
The company added Pittman is a graduate of the University of Texas at Arlington as well as an MBA from the LeTourneau University in Texas.
Merck announces Phase 3 trials for once-monthly oral HIV prevention pill MK-8527
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
Estrella Immunopharma initiates second cohort in EB103 trial for advanced B-cell lymphomas
bioMérieux receives CE-marking for LUMED APSS to support antimicrobial stewardship in Europe
Merck reports positive Phase 3 Data on HIV treatment DOR/ISL
QOL Medical's Sucraid shows 81% effectiveness in Congenital Sucrase-Isomaltase Deficiency
Qlucore launches first CE-marked diagnostic test for paediatric leukaemia
Bruker demonstrates advancements in 4D-Proteomics at US HUPO
Mitem Pharma acquires Flisint rights from Sanofi to address rare infectious disease
Audientes partners with Audivista to expand hearing solutions in Middle East and North Africa
Benuvia Operations signs licensing deal with Avernus Pharma
Benuvia Operations signs licensing and supply agreements with Medra Brasil Medicamentos
Castle Biosciences to present data on Melanoma tests at ASDP Annual Meeting
Alchemy partners with PatchRx to improve HIV medication adherence